DIVA Laboratories Ltd (4153) - Total Liabilities

Latest as of December 2025: NT$324.52 Million TWD ≈ $10.22 Million USD

Based on the latest financial reports, DIVA Laboratories Ltd (4153) has total liabilities worth NT$324.52 Million TWD (≈ $10.22 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore DIVA Laboratories Ltd annual equity growth to track the company's year-over-year net asset growth rate.

DIVA Laboratories Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how DIVA Laboratories Ltd's total liabilities have evolved over time, based on quarterly financial data. See DIVA Laboratories Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

DIVA Laboratories Ltd Competitors by Total Liabilities

The table below lists competitors of DIVA Laboratories Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Top Systems-L TA:TOPS	Israel	ILA234.43 Million
Sempio Foods KO:007540	Korea	₩124.92 Billion
Lowell Resources Fund AU:LRT	Australia	AU$2.41 Million
ktcs corporation KO:058850	Korea	₩211.36 Billion
News Network Corporation Public Company Limited BK:NEWS	Thailand	฿1.00 Billion
Taiwan Ostor TWO:8080	Taiwan	NT$469.81 Million
Yonyu Plastics Co Ltd TW:1323	Taiwan	NT$2.17 Billion
Razor Labs Ltd TA:RZR	Israel	ILA54.66 Million

Liability Composition Analysis (2017–2025)

This chart breaks down DIVA Laboratories Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DIVA Laboratories Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.35	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.32	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how DIVA Laboratories Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for DIVA Laboratories Ltd (2017–2025)

The table below shows the annual total liabilities of DIVA Laboratories Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$324.52 Million ≈ $10.22 Million	+29.84%
2024-12-31	NT$249.94 Million ≈ $7.87 Million	+18.50%
2023-12-31	NT$210.93 Million ≈ $6.65 Million	-10.48%
2022-12-31	NT$235.62 Million ≈ $7.42 Million	+20.66%
2021-12-31	NT$195.27 Million ≈ $6.15 Million	+57.05%
2020-12-31	NT$124.34 Million ≈ $3.92 Million	-26.03%
2019-12-31	NT$168.09 Million ≈ $5.30 Million	+21.05%
2018-12-31	NT$138.87 Million ≈ $4.38 Million	-45.51%
2017-12-31	NT$254.84 Million ≈ $8.03 Million	--

About DIVA Laboratories Ltd

TWO:4153 Taiwan Diagnostics & Research

Market Cap

$57.30 Million

NT$1.82 Billion TWD

Market Cap Rank

#21363 Global

#1311 in Taiwan

Share Price

NT$31.00

Change (1 day)

+0.00%

52-Week Range

NT$29.75 - NT$41.50

All Time High

NT$76.08